X
Xeris Biopharma Holdings, Inc.
XERS · NASDAQ · Healthcare · 1.5B
Price · close
$8.70
+1.16% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
2519.3×
Price / net assetsP/B
102.0×
Enterprise value / EBITDAEV/EBITDA
104.0×
Free cash flow yieldFCF yield
2.0%
Return on equityROE
4.0%
Operating margin
8.5%
Net debt / EBITDAbalance-sheet strength
-5.8×
Interest coverage
0.9×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.